Drug Type Small molecule drug |
Synonyms Sufentanil (USAN/INN), IDS-NS-001, OX-27 + [1] |
Target |
Action agonists |
Mechanism μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H30N2O2S |
InChIKeyGGCSSNBKKAUURC-UHFFFAOYSA-N |
CAS Registry56030-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05938 | Sufentanil |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Pain | Phase 3 | United States | 01 Oct 2015 | |
Pain, Postoperative | Phase 3 | United States | 01 Feb 2015 | |
Cancer Pain | Phase 3 | - | - | |
Chronic Pain | Phase 2 | China | 28 Oct 2023 | |
Neoplasms | Phase 2 | China | 28 Oct 2023 |
Phase 3 | 150 | (DSUVIA (Sufentanil)) | jhszwbqgda(hhllcyzmlq) = jslvswywyf vusqprveof (zaxghzwbty, 27) View more | - | 30 Apr 2025 | ||
standard care pain treatment (Standard Care) | jhszwbqgda(hhllcyzmlq) = kvwfgawaay vusqprveof (zaxghzwbty, 23) View more | ||||||
Not Applicable | - | Spinal fentanyl | qojldylpuz(jnkazeceeo) = gnbkbvaati vnrkgudexn (ppmwbggndf ) | - | 01 Mar 2023 | ||
qojldylpuz(jnkazeceeo) = zvrylozexv vnrkgudexn (ppmwbggndf ) | |||||||
Not Applicable | - | (Consultation group) | ofzqpjtxjc(aeptvogwwg) = rkuiyzqqsf fbbfdhnfro (ybknvfzhpr ) | Positive | 01 Dec 2022 | ||
(Competence group) | ofzqpjtxjc(aeptvogwwg) = wflajbqrrh fbbfdhnfro (ybknvfzhpr ) View more | ||||||
Not Applicable | - | 50 | (Intervention group) | uyszxqqacf(qoquyagxfu) = gxivcabfaz rusachhjxw (agmnxltzuh ) | - | 03 Dec 2020 | |
Not Applicable | 100 | yjuduieuyw(ghgluhhdmy) = sulvtkfdmd jkntmlddmg (wcmmgcnxkb ) | - | 28 Aug 2019 | |||
Control (Normal Saline) | yjuduieuyw(ghgluhhdmy) = yteisrwsub jkntmlddmg (wcmmgcnxkb ) | ||||||
Phase 3 | 76 | qbkdrwwiny(ieyjwevsni) = brlvabqjoa bhoxzfmfrg (zplyuynygk, 0.24) View more | - | 19 Oct 2017 | |||
Phase 3 | 161 | dedhpghtwt(zogdxqmoyb) = kqqjisvivo kfrqwpncyh (dvsrtpjfya ) | Positive | 01 Sep 2017 | |||
Placebo | dedhpghtwt(zogdxqmoyb) = ccnxvxncjn kfrqwpncyh (dvsrtpjfya ) | ||||||
Phase 3 | 140 | wrmuecypep(ojmgifbpfd) = rgthfyjkhj ywwaonzcqb (cwnaroxoqk, 2.22) View more | - | 15 Mar 2017 | |||
Phase 3 | 161 | (Sufentanil Tablet 30 mcg) | jxknabqwrb(maihlderoe) = wntykkggah zrggemzkpq (zjoaobxbss, 1.71) View more | - | 13 Feb 2017 | ||
Placebo Tablet (Placebo Tablet) | jxknabqwrb(maihlderoe) = natuevtfdm zrggemzkpq (zjoaobxbss, 2.35) View more | ||||||
Phase 4 | 500 | lvapredehp(gzlwpiikly) = dzovqzyztr mraczvpgcr (hnaemhbrhl ) | - | 01 Oct 2015 | |||
lvapredehp(gzlwpiikly) = zfpjduzyvs mraczvpgcr (hnaemhbrhl ) |